Therapeutic potential of exosomal lncRNAs derived from stem cells in wound healing: focusing on mesenchymal stem cells
Ali Morabbi,
No information about this author
Mohammad Karimian
No information about this author
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 11, 2025
The
self-renewal
ability
and
multipotency
of
stem
cells
give
them
great
potential
for
use
in
wound
healing.
Stem
cell-derived
exosomes,
owing
to
their
close
biological
resemblance
parent
cells,
offer
a
more
efficient,
safer,
economical
approach
facilitating
cellular
communication
interactions
within
different
environments.
This
makes
particularly
valuable
the
treatment
both
acute
chronic
wounds,
such
as
lacerations,
burns,
diabetic
ulcers.
Long
non-coding
RNAs
(lncRNAs)
enclosed
one
leading
actors
these
extracellular
microvesicles,
through
interaction
with
miRNAs
regulation
various
signaling
pathways
involved
inflammation,
angiogenesis,
cell
proliferation,
migration,
could
heal
wounds.
Exosome-derived
lncRNAs
from
facilitate
matrix
remodeling
between
macrophages
fibroblasts.
Moreover,
alongside
regulating
expression
inflammatory
cytokines,
controlling
reactive
oxygen
species
levels,
enhancing
autophagic
activity,
they
also
modulate
immune
responses
support
Regulating
genes
related
by
increasing
blood
supply
accelerating
delivery
essential
substances
environment,
is
another
effect
exosomal
derived
These
can
enhance
skin
healing
homeostasis,
proliferation
differentiation
wound-healing
process,
fibroblast
viability
migration
injury
site.
Ultimately,
exosome-derived
novel
insights
into
molecular
mechanisms
underlying
improved
They
pave
way
therapeutic
strategies,
fostering
further
research
better
future.
Meanwhile,
exosomes
mesenchymal
due
exceptional
regenerative
properties,
well
have
emerged
innovative
tools
review
article
aims
narrate
roles
focus
on
cells.
Language: Английский
Senescence in Adipose-Derived Stem Cells: Biological Mechanisms and Therapeutic Challenges
Riccardo Foti,
No information about this author
Gabriele Storti,
No information about this author
Marco Palmesano
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8390 - 8390
Published: Aug. 1, 2024
Adipose
tissue-derived
stem
cells
(ADSCs)
represent
a
subset
of
the
mesenchymal
in
every
adipose
compartment
throughout
body.
ADSCs
can
differentiate
into
various
cell
types,
including
chondrocytes,
osteocytes,
myocytes,
and
adipocytes.
Moreover,
they
exhibit
notable
potential
to
vitro
from
other
germinal
lineages,
endothelial
neurons.
have
wide
range
clinical
applications,
breast
surgery
chronic
wounds.
Furthermore,
are
promising
population
for
future
tissue-engineering
uses.
Accumulating
evidence
indicates
decreased
proliferation
differentiation
with
an
increasing
age,
body
mass
index,
diabetes
mellitus,
metabolic
syndrome,
or
exposure
radiotherapy.
Therefore,
recent
literature
thoroughly
investigates
this
population’s
senescence
mechanisms
how
hinder
its
possible
therapeutic
applications.
This
review
will
discuss
biological
physio-pathological
causes
behind
ADSC
impact
cellular
functionality.
we
examine
strategies
invert
these
processes,
re-establishing
full
regenerative
progenitor
population.
Language: Английский
Pseudogene: Relevant or Irrelevant?
Yang-Hsiang Lin,
No information about this author
Chau‐Ting Yeh,
No information about this author
Cheng‐Yi Chen
No information about this author
et al.
Biomedical Journal,
Journal Year:
2024,
Volume and Issue:
unknown, P. 100790 - 100790
Published: Sept. 1, 2024
Language: Английский
HES1 revitalizes the functionality of aged adipose-derived stem cells by inhibiting the transcription of STAT1
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 5, 2024
The
effectiveness
of
adipose-derived
stem
cells
(ADSCs)
in
therapy
diminishes
with
age.
It
has
been
reported
that
transcription
factors
(TFs)
play
a
crucial
role
the
aging
and
functionality
cells.
Nevertheless,
there
is
limited
understanding
regarding
involvement
TFs
mechanism
ADSCs.
RNA
sequencing
(RNA-seq)
was
utilized
to
discern
differentially
expressed
genes
ADSCs
obtained
from
donors
varying
ages.
exhibiting
significant
variations
across
age
groups
were
identified
subsequently
validated.
manipulated
exhibit
either
enhanced
expression
or
reduced
levels
HES1
STAT1
via
lentivirus
transfection
small
interfering
(siRNA)
techniques.
impact
these
genetic
alterations
on
ADSCs'
proliferation,
migration,
cellular
senescence
assessed
using
EdU,
transwell,
senescence-activated
β-galactosidase
(SA-β-gal)
staining
assays.
DNA
sequences
bound
by
investigated
through
CUT
&
Tag
assay.
Lastly,
therapeutic
efficacy
aged
overexpression
evaluated
skin
injury
model
male
Sprague-Dawley
rats.
678
showed
differential
between
young
old
(Y-ADSCs
O-ADSCs),
47
being
TFs.
Notably,
TF
hairy
enhancer
split
1
(HES1)
notably
donors.
Introducing
resulted
improved
function
suppression
senescence,
while
reducing
had
opposite
effect.
Mechanistically,
found
interact
promoter
region
another
TF,
signal
transducer
activator
(STAT1),
inhibit
its
transcription.
Knocking
down
could
fully
reverse
negative
effects
caused
decreased
ADSCs,
leading
reduction
secretion
pro-inflammatory
cytokines
such
as
TNF-α,
IL-6,
IL-8.
Ultimately,
restoring
demonstrated
potential
promoting
wound
healing.
acts
an
inhibitor
progression
modulation
expression,
suggesting
promising
avenue
for
rejuvenating
senescent
improving
Language: Английский